Neuropathy in adolescents with type 1 diabetes: Confirmatory diagnostic tests, bedside tests, and risk factors

Aims: To estimate the prevalence of large fiber (LFN), small fiber (SFN), and autonomic neuropathy in adoles-cents with type 1 diabetes using confirmatory tests known from adults and to identify risk factors and bedside methods for neuropathy.Methods: Sixty adolescents with type 1 diabetes (diabetes duration > five years) and 23 control subjects un-derwent neurological examination and confirmatory diagnostic tests for neuropathy, including nerve conduction studies, skin biopsies determining intraepidermal nerve fiber density, quantitative sudomotor axon reflex test (QSART), cardiovascular reflex tests (CARTs), and tilt table test. Possible risk factors were analyzed. Bedside tests (biothesiometry, DPNCheck & REG;, Sudoscan, and Vagus & REG;device) were compared with the confirmatory tests using ROC analysis.Results: The prevalence of neuropathies in the adolescents with diabetes (mean HbA1c 7.6% (60 mmol/mol)) was as follows: 14% confirmed/26% subclinical LFN, 2% confirmed/25% subclinical SFN, 20% abnormal QSART, 8% abnormal CARTs, and 14% orthostatic hypotension. Higher age, higher insulin dose, previous smoking, and higher triglycerides level were found to increase the relative risk for neuropathy. The bedside tests showed poor to acceptable concordance with the confirmatory tests (all, AUC & LE; 0.75).Conclusions: The diagnostic tests confirmed the presence of neuropathy in adolescents with diabetes and un-derscore the importance of prevention and screening.

Automated summary

The aim of this study was to estimate the prevalence of neuropathy in adolescents with type 1 diabetes and identify risk factors and bedside methods for neuropathy. The diagnostic tests confirmed the presence of neuropathy and emphasized the importance of prevention and screening.